FDA approves brain wave test for ADHD


The approval from the Food and Drug Administration (FDA) should help doctors detect the condition, which affects more than 5 million children in United States, the agency said.

“When used as part of a complete medical and psychological examination, the device can help confirm an ADHD diagnosis or a clinician’s decision that further diagnostic testing should focus on ADHD or other medical or behavioral conditions that produce symptoms similar to ADHD,” the agency said in its announcement.

When used with other tools, the new system, made by Georgia-based NEBA Health, “may help health care providers more accurately determine if ADHD is the cause of a behavioral problem,” said the director of FDA’s device evaluation office, Christy Foreman, in a statement.

Children who have ADHD have a hard time paying attention, controlling their behavior and often display hyperactive behavior.

The new device is called the NEBA System.